PD09-12 THE USE OF <sup>68</sup> Ga-FAP-2286 PET IMAGING IN PATIENTS WITH LOCALIZED BLADDER CANCER
Domenique Escobar(University of California, San Francisco), Sima P. Porten(City College of San Francisco), Vadim S. Koshkin(UCSF Helen Diller Family Comprehensive Cancer Center), Brad Kline(University of California, San Francisco), Vipul Kumar(University of California, San Francisco), Thomas A. Hope(Fondazione IRCCS Istituto Nazionale dei Tumori), Maxwell V. Meng(University of California, San Francisco), Terence W. Friedlander(University of California, San Francisco), Jonathan Chou(UCSF Helen Diller Family Comprehensive Cancer Center)
Cited by 2
Related Papers
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
|JAMA Oncology|2017|846
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|185
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|184
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
|Clinical Cancer Research|2021|154